This is a speculative opinion...so as always...DYOR.
My understanding is that PRR (and for that matter the FDA) have a moral (and probably legal) requirement to suspend any trial if the trial group was being affected by a trial. That is to say...if a trial was detrimental to the trial group it would have to cease.....on moral as well as probably legal grounds.
I would also assume that any inclusion of other cancers in a trial would require FDA approval. To allow for the above assumption, PRR must be kept in the loop about the progress of trials they undertake, to ensure no bad effects are occurring.
If I am correct, and any additional trial requires FDA approval.........then all must be good with the existing trial.
We can only wait and see.
GLTA
PRR Price at posting:
7.8¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)